| Course | MMHA 6050 Delivery of Healthcare |
|---|---|
| Week | Week 7 |
| Paper type | International health system comparison |
| Length | About 1,010 words, 6 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Master of Healthcare Administration (MHA) |
| Updated | October 2026 |
Free sample paper for MMHA 6050 Week 7
The United States, Canada and Germany Scored on Access, Cost and Quality
Student Name
Walden University
MMHA 6050: Delivery of Healthcare
Instructor Name
Month Day, Year
The United States, Canada and Germany Scored on Access, Cost and Quality
Choosing the Comparators
This paper compares the United States with two peer systems chosen to represent different financing designs among wealthy countries. Canada finances hospital and physician care through provincial single-payer insurance plans. Germany finances care through statutory health insurance with many competing, tightly regulated sickness funds, alongside a smaller private insurance sector (Tikkanen et al., 2020). Both are wealthy democracies, so differences in performance are more likely to reflect how care is financed and organized than how rich each country is.
The Scoring Scale
Each criterion is scored on three levels, defined before any country is scored. Access: strong means nearly universal coverage and low cost-related barriers to care; moderate means universal coverage with significant waits or coverage gaps for some services; weak means a substantial share of people uninsured or underinsured, with cost a common barrier. Cost: strong means spending per person and as a share of the economy near or below the peer average; moderate means somewhat above; weak means well above. Quality: strong means outcomes, such as deaths preventable by health care, better than the peer average; moderate means near the average; weak means worse.
The domain structure follows the Commonwealth Fund's Mirror, Mirror reports, which group performance into areas such as access to care, care process, administrative efficiency, equity and health outcomes (Blumenthal et al., 2024). This paper keeps to the course's three criteria and does not reproduce the reports' country placements.
The Scored Grid
Table 1 shows the scores and the evidence behind each.
Table 1
Access, Cost and Quality Scores With Basis
| Criterion | United States | Canada | Germany |
|---|---|---|---|
| Access | Weak: about 92.5% insured in 2023 (Martin et al., 2025), with cost-related barriers common | Moderate: universal coverage for hospital and physician care; long waits for specialist and elective care; outpatient drugs not universally covered | Strong: near-universal coverage through statutory or private insurance; relatively short waits |
| Cost | Weak: highest spending per person among OECD countries and about 17.6% of the economy in 2023 | Moderate: spending above the OECD average but far below the United States | Moderate: among the higher spenders in Europe, far below the United States |
| Quality | Weak to moderate: strong on some care processes; life expectancy and preventable mortality worse than peers | Moderate: outcomes near or better than peer average on many measures | Moderate: outcomes near peer average on many measures |
Access
The United States scores weakest on access because of its coverage design. Even with the insured share at a record high of about 92.5% in 2023 (Martin et al., 2025), millions lack coverage, and many insured people face deductibles and cost sharing that deter care. Canada's provincial plans cover hospital and physician care for everyone without charges at the point of care, but long waits for specialist and elective care, and gaps in coverage for outpatient prescription drugs, limit access in practice (Tikkanen et al., 2020). Germany combines near-universal coverage with relatively short waits, which earns it the strongest score. Each system's access problem follows from its design: the U.S. problem is coverage and cost, Canada's is capacity and scope, and Germany's is comparatively small, though not absent in rural regions.
Cost
On cost, the United States is an outlier. It spends far more per person than any other OECD country, and its spending share of the economy, about 17.6% in 2023 (Martin et al., 2025), is well above Canada's and Germany's (OECD, 2023). Canada and Germany both spend above the OECD average, but at levels far below the United States. Part of the U.S. difference reflects higher prices for the same services and higher administrative costs associated with many payers and complex billing; Germany's many sickness funds suggest that multiple insurers alone do not explain U.S. costs, since Germany regulates benefits and prices much more tightly. Price regulation, more than the number of payers, appears to separate the two.
Quality
Quality is the hardest criterion to score, because the United States performs well on some care processes, such as certain screening and cancer survival measures, and poorly on population outcomes. Life expectancy in the United States is lower than in Canada and Germany, and deaths that could have been prevented with timely, effective care are more common (OECD, 2023). The U.S. score of weak to moderate reflects that mix. Canada and Germany score moderate, with outcomes near or better than peer averages on many measures.
Limits of This Comparison
The scores rest on national averages, which hide wide variation within each country. Access and quality in the United States differ greatly by state, insurance type and income; a well-insured American in a well-served city may have faster access to specialists than most Canadians, while an uninsured American in a rural county may have far less than anyone in Germany. Canada's waits vary by province and specialty. The three-level scale is also coarse: it separates clear differences but cannot rank close ones, and a reader with different thresholds might score Germany's cost as weak or Canada's quality as strong. Finally, quality measures such as preventable mortality reflect more than health care, including social conditions, diet and violence, which differ across the three countries. These limits do not overturn the broad pattern, which other comparisons, including the Commonwealth Fund's reports, also find, but they caution against reading the grid as a precise ranking. It is a structured way to see where each design tends to succeed and fail, and why.
What the Comparison Shows
The comparison suggests that financing design shapes performance more than whether a system uses one payer or many. Canada and Germany differ sharply in structure but share universal coverage, tight regulation of prices and benefits and lower spending than the United States. For a U.S. health administrator, the lesson is not to copy either system, which national policy would have to do, but to recognize which of the U.S. system's weaknesses an organization can address directly, such as reducing cost-related barriers for its own patients or simplifying administrative processes, and which depend on national financing design beyond any one organization's control.
References
Blumenthal, D., Gumas, E. D., Shah, A., Gunja, M. Z., & Williams, R. D., II. (2024). Mirror, mirror 2024: A portrait of the failing U.S. health system. The Commonwealth Fund.
Martin, A. B., Hartman, M., Washington, B., Catlin, A., & National Health Expenditure Accounts Team. (2025). National health expenditures in 2023: Faster growth as insurance coverage and utilization increased. Health Affairs, 44(1), 12-22. https://doi.org/10.1377/hlthaff.2024.01375
OECD. (2023). Health at a glance 2023: OECD indicators. OECD Publishing.
Tikkanen, R., Osborn, R., Mossialos, E., Djordjevic, A., & Wharton, G. A. (2020). International profiles of health care systems. The Commonwealth Fund.
Reading the MMHA 6050 Week 7 instructions
Comparing the U.S. system with peers is the task here. Choose comparators deliberately and say why, ideally ones that differ in financing design but not in wealth. Define a scoring scale for each criterion before scoring any country. If you borrow a structure from a published report, credit it and avoid simply reproducing its rankings. Score each country on each criterion in a grid that states the basis for every score, with sources. Explain the scores in prose, criterion by criterion. Acknowledge the comparison's limits, such as national averages hiding variation and outcome measures reflecting more than health care. Close with what the comparison means for a U.S. administrator, separating what an organization can address from what depends on national policy.
Inside the MMHA 6050 Week 7 example
The opening explains choosing Canada and Germany for their financing designs. A section defines strong, moderate and weak for each criterion and credits the Mirror, Mirror domain structure. Table 1 scores each country with its basis. The access section explains U.S. coverage and cost barriers, Canadian waits and drug gaps and German near-universal coverage, citing Martin and colleagues and Tikkanen and colleagues. The cost section uses OECD comparisons and notes price regulation. The quality section explains the U.S. mix of process strengths and outcome weaknesses. A limits section discusses variation and coarse scoring. The close separates organizational from national levers. Every score in the grid names its source.
Where the marks sit in the MMHA 6050 Week 7 rubric
International comparisons are judged on whether verdicts are built from stated standards. A paper that cites a published ranking and agrees with it earns little credit. Deliberate choice of comparators earns the first share. A scale defined before scoring earns the next. A grid with the basis for every score, sourced, carries the largest share. Explaining the scores criterion by criterion shows understanding of why each design performs as it does. A limits section shows judgment, and a close that separates what an organization can address from national policy shows practical value. Crediting borrowed structures without reproducing placements is expected. Accurate, current figures complete the assessment.
Common MMHA 6050 Week 7 mistakes, and how to avoid them
International papers often summarize a well-known ranking and explain why the United States does poorly. That reports someone else's verdict. Instead, pick two comparators with different financing designs, define what strong, moderate and weak mean for each criterion and then score each country yourself, writing the evidence for every score. If your scores differ from a published ranking, that is fine, provided your basis is clear. Finally, ask what a U.S. health system leader could actually do with the result. We can write an international comparison that scores the United States and peers on stated criteria with evidence for every cell. Readers trust a grid more when they can see how each cell was filled.
Get a MMHA 6050 Week 7 example written to your instructions
A scored MMHA 6050 Week 7 comparison waits at this desk, its scale declared up front and each cell carrying an evidence note. No published league-table position is copied into it. Send the prompt and the rubric your section posted; the first custom sample is free and comes back in 24-48h.
More MMHA 6050 papers and MHA samples
- MMHA 6050 Week 1: Health System Components Post
- MMHA 6050 Week 2: Provider Payer Patient Interest Map
- MMHA 6050 Week 3: Hospital and Ambulatory Comparison
- MMHA 6050 Week 4: Health Financing Stream Trace
- MMHA 6050 Week 5: Health Workforce Tradeoff Post
- MMHA 6050 Week 6: Quality Aims Application Paper
- MMHA 6050 Week 8: Emerging Delivery Models Post
- MMHA 6050 Week 9: Sourced Section Drafts Paper
- MMHA 6050 Week 10: Peer Review and Revision Package
- MMHA 6050 Week 11: Full Delivery System Analysis
- MMHA 5500 Week 7: Performance Appraisal Design Paper
- MMHA 6400 Week 5: Financial Analysis
MMHA 6050 Week 7 questions, answered
Where can I find a free MMHA 6050 Week 7 sample paper?
The international comparison and its scored grid are open to read here.
Which countries does the MMHA 6050 Week 7 paper compare?
The United States, Canada with provincial single-payer plans and Germany with regulated multiple sickness funds.
How are the scores built?
On a three-level scale defined for each criterion before any country is scored, with the basis for each score stated.
How does the United States score?
Weak on access and cost, and weak to moderate on quality, with strong care processes but worse population outcomes.
What does the comparison suggest?
That universal coverage and tight price regulation matter more to performance than whether a system has one payer or many.